Comparison of four regions in the replicase gene of heterologous infectious bronchitis virus strains  by Mondal, Shankar P & Cardona, Carol J
www.elsevier.com/locate/yviro
Virology 324 (2004) 238–248Comparison of four regions in the replicase gene of heterologous
infectious bronchitis virus strains
Shankar P. Mondal and Carol J. Cardona*
Department of Population Health and Reproduction, University of California, Davis, CA 95616, USAReceived 15 December 2003; returned to author for revision 9 January 2004; accepted 24 March 2004Abstract
Infectious bronchitis virus (IBV) produces six subgenomic (sg) mRNAs, each containing a 64 nucleotide (nt) leader sequence, derived
from the 5V end of the genome by a discontinuous process. Several putative functional domains such as a papain-like proteinase (PLpro),
main protease (Mpro), RNA-dependent RNA polymerase (RdRp), and RNA helicase encoded by the replicase gene are important for virus
replication. We have sequenced four regions of the replicase genes corresponding to the 5V-terminal sequence, PLpro, Mpro, and RdRp
domains from 20 heterologous IBV strains, and compared them with previously published coronavirus sequences. All the coronavirus 5V-
termini and PLpro domains were divergent, unlike the Mpro and the RdRp domains that were highly conserved with 28% and 48%
conserved residues, respectively. Among IBV strains, the 5V untranslated region including the leader sequence was highly conserved
(>94% identical); whereas, the N-terminal coding region and the PLpro domains were highly variable ranging from 84.6% to 100%, and
77.6% to 100% identity, respectively. The IBV Mpro and RdRp domains were highly conserved with 82.7% and 92.7% conserved
residues, respectively. The BJ strain was the most different from other IBVs in all four regions of the replicase. Phylogeny-based
clustering based on replicase genes was identical to the antigen-based classification of coronaviruses into three groups. However, the IBV
strain classification based on replicase gene domains did not correlate with that of the type-specific antigenic groups. The replicase gene
sequences of many IBVs recovered from infected chickens were identical to those of vaccine viruses irrespective of serotype, suggesting
that either there has been an exchange of genetic material among vaccine and field isolates or that there is a convergent evolution to a
specific replicase genotype. There was no correlation between the genotype of any region of the replicase gene and pathotype, suggesting
that the replicase is not the sole determinant of IBV pathogenicity.
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Introduction cial flocks occur when new viruses emerge from existingAvian infectious bronchitis virus (IBV), the prototype
species of the family Coronaviridae, causes an acute and
highly contagious disease of chickens. Numerous IBV
strains exist, and clinical signs of the disease they cause
vary from mild to severe. More than 20 IBV serotypes have
been recognized worldwide, which are defined by cross-
reactivity among the structural proteins (Cowen and Hitch-
ner, 1975; Hopkins, 1974). Live vaccines containing strains
of IBV from multiple serotypes are routinely used in
commercial chicken flocks. Disease outbreaks in commer-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: cjcardona@ucdavis.edu (C.J. Cardona).viruses by mutations, insertions, deletions, or recombination
(Cavanagh et al., 1992; Gelb et al., 1991; Kusters et al.,
1990). However, because these conclusions are based on
available sequence from structural genes, viral evolution has
only been described for this small part of the genome.
Because only two IBVs have been fully sequenced, it has
been impossible to fully understand the viral evolutionary
process including the extent to which vaccine viruses have
contributed genetic material to pathogenic field strains.
Six subgenomic (sg) mRNA species are transcribed from
the IBV genome in virus-infected cells. This includes a
genome-length mRNA (mRNA 1) of 27.6 kb and five sg
species (mRNA 2–6) with sizes ranging from 2 to 7 kb.
These mRNAs form a 3V-co-terminal nested structure (Stern
and Sefton, 1984), each containing a short nontranslated
leader sequence (64 nucleotides (nt)), derived from the 5V
S.P. Mondal, C.J. Cardona / Virology 324 (2004) 238–248 239end of the genome by a discontinuous process. The phe-
nomenon of leader switching has been described for several
coronaviruses including IBV (Chang et al., 1994; Makino et
al., 1988; Stirrups et al., 2000). The mRNA 1 contains two
large overlapping open reading frames (ORF 1a and 1b)
encoding 441- and 300-kDa polyproteins, respectively
(Boursnell et al., 1987). By a unique frameshifting mecha-
nism, the downstream ORF 1b is produced as a fusion
protein of 741 kDa with 1a (Brierley et al., 1987, 1989).
These polyproteins are proteolytically processed into
smaller products required for RNA synthesis and other
aspects of viral replication. Four main structural proteins
are encoded by sgmRNAs: the spike (S) glycoprotein
(mRNA 2), the small envelope (E) protein (mRNA 3), the
membrane (M) glycoprotein (mRNA 4), and the nucleocap-
sid (N) protein (mRNA 6) (Lai, 1990; Spaan et al., 1988;
Sutou et al., 1988). The S1 fragment of the spike protein
carries antigenic epitopes that induce virus-neutralizing
(VN) antibody, and also determines virus serotype (Cav-
anagh and Davis, 1986; Cavanagh et al., 1986).
Two overlapping papain-like proteinase (PLpro) domains
encoded between nucleotides (nt) 4243 and 5553 (amino
acids (aa) 1239–1675), and a picornavirus 3C-like protein-
ase (3C-LP) domain encoded between nt 8937 and 9357 (aa
2804–2943), are involved in the production of mature viral
proteins required for replication (Liu and Brown, 1995; Liu
et al., 1994, 1995, 1997). Proteolytic processing of the
polyproteins by equivalent protease activities has been
demonstrated in murine and human coronaviruses (reviewed
in Lim et al., 2000; Ng and Liu, 2000). Despite the
conservation of function, there are some organizational
differences in PLpro domains between IBV and some other
coronaviruses (Herold et al., 1993; Lee et al., 1991).
Because of its key role in replicase gene expression, 3C-
LP has been termed the coronavirus main protease (Mpro;
Ziebuhr et al., 2000). The IBV PLpro domain-1 (PL1pro),
encoded between nt 4243 and 5019 (aa 1239–1497), is
responsible for cleavage of the N-terminal regions of 1a and
1a/1b polyproteins in IBV-infected cells, whereas the PLpro
domain-2 (PL2pro) encoded between nt 4681–5553 (aa
1385–1675) is reported to be functionally inactive in IBV
(Lim and Liu, 1998; Lim et al., 2000; Liu et al., 1995). A
more important role in the processing of polyproteins is
played by the Mpro, which is responsible for the cleavage of
other regions of the ORF 1a and 1a/1b polyproteins (Liu et
al., 1994, 1997, 1998; Ng and Liu, 1998, 2002). The
catalytic center of both proteinases consists of His and
Cys residues in all coronaviruses (reviewed in Lim et al.,
2000; Ng and Liu, 2000). The processed products constitute
a group of replicative enzymes, including the RNA-depen-
dent RNA polymerase (RdRp) and RNA helicase. There-
fore, the significance of the coronavirus leader sequence and
several putative functional domains essential for viral rep-
lication made them logical choices for sequence analysis
and phylogenetic comparisons to correlate with the serolog-
ical or pathological classification of coronaviruses.Phylogeny-based clustering based on replicase genes is
identical to the original antigen-based classification of
coronaviruses (Chouljenko et al., 2001; Hegyi and Ziebuhr,
2002; Stephensen et al., 1999). However, within the group 3
coronaviruses, no comparisons of replicase-based and anti-
gen-based phylogenies have been made. One report has
described the alignment of the 5V-proximal region of repli-
case genes from a limited number of IBV strains (Stirrups et
al., 2000), and a few reports describe IBV Mpro and RdRp
domains from the Beaudette strain only (Hegyi and Ziebuhr,
2002; Stephensen et al., 1999). Here, we have sequenced
four regions of the replicase gene corresponding to the 5V-
terminal end, PLpro, Mpro, and RdRp domains from 20
heterologous IBV strains, and compared then with previ-
ously published IBV and other coronavirus sequences. We
present evidence that (i) the Mpro and RdRp regions are
highly conserved among all coronaviruses unlike the 5V-
terminal sequence and PLpro domains, (ii) the clustering of
heterologous IBV strains based on the replicase gene
sequences does not correlate with the antigen-based S1
phylogeny, (iii) several widely used IBV vaccines and field
strains isolated over the past decade have closely related
replicase genes suggestive of a possible common ancestry or
a converging evolution, and (iv) the replicase gene is
unlikely to be the sole determinant of IBV pathogenicity.Results
The 5V -terminal sequences (nt 1–1263)
The nt sequence alignment data obtained from the IBV
5V-termini are presented in Table 1, Figs. 1 and 2a. The
leader sequences (nt 1–64) of H52, CU705, CU510, Ark99,
ArkDPI, CU805, CU570, GA98, Cal99, CU994, K1699,
Gray, and BJ strains are identical to each other and each
have 3 nt substitutions compared to the Beaudette strain
(Fig. 1). The DE072 virus has four, the vaccine and
challenge M41 strains, and CU-T2 have three, Ma5,
K0751, and Florida have two, and Conn has a single nt
substitution compared to the Beaudette strain (Fig. 1). The
leader junction sequences termed as leader transcription-
regulating sequences (TRSs) are absolutely conserved in all
of the IBV strains compared. The sequence distance data
(Table 1) obtained from the whole 5V UTR (nt 1–528)
indicate that nt sequence identities were 94–100% among
all IBV strains in this region. The N-terminal coding region
(nt 529–1263) of the 5V terminal sequence is more variable
with the lowest identity represented by the BJ strain at 84.6–
86% identity with the other strains. Pairwise comparisons of
the N-terminal sequences from other strains revealed 89.7–
100% identity irrespective of serotype, geographic source,
and virulence (Table 1). The challenge strain NV M41 is
identical to the vaccine strain M41 in the noncoding region
but in the coding region has a single nt change that results in
an amino acid change (data not shown). These relationships
Table 1
Nucleotide identities in the 5V UTR (nt 1–528: right-hand side) and the N-terminal coding region (nt 529–1263) of the replicase gene of 21 IBV strains
Virus 5V UTR
Beau M41a Ma5 H52 K0
751
CU
705
Conn CU
510
Flori CU
T2
Ark
99
Ark
DPI
DE
072
CU
805
CU
570
GA
98
Cal
99
CU
994
K1
699
Gra BJ
Beau 98.7 97.2 96.2 96.6 96.4 97.0 96.2 96.4 96.2 96.0 96.2 95.8 96.2 96.4 96.0 95.6 96.0 94.3 95.8 94.7
M41a 92.9 96.8 97.2 97.5 97.3 97.0 97.2 96.8 97.2 96.6 97.2 96.8 97.2 97.3 97.0 96.6 97.0 95.3 96.8 94.9
Ma5 94.6 93.3 99.6 99.2 98.7 97.2 99.2 96.6 98.5 97.2 99.6 99.2 98.9 99.4 99.4 99.1 99.4 96.0 99.2 95.1
H52 94.6 93.3 100 99.6 99.1 97.2 99.6 97.0 98.9 97.5 100 99.6 99.2 99.8 99.8 99.4 99.8 96.4 99.6 95.5
K0751 94.1 93.2 99.3 99.3 99.1 97.5 99.2 97.3 99.2 97.5 99.6 99.2 99.2 99.4 99.4 99.1 99.4 96.2 99.2 95.3
CU705 94.0 92.8 98.6 98.6 98.0 97.3 98.7 97.2 99.1 97.7 99.1 98.7 99.4 98.9 98.9 98.5 98.9 96.8 98.7 95.8
Conn 94.4 93.3 98.2 98.2 97.6 97.1 97.2 99.4 97.2 97.3 97.2 96.8 97.2 97.0 97.0 96.6 97.0 95.1 96.8 94.2
CU510 94.4 93.2 99.7 99.7 99.0 98.4 98.0 97.0 98.5 97.2 99.6 99.2 98.9 99.4 99.4 99.2 99.4 96.0 99.2 95.1
Florida 94.4 93.3 98.2 98.2 97.6 97.1 99.7 98.0 97.0 97.2 97.0 96.6 97.0 96.8 96.8 96.4 96.8 94.9 96.6 94.0
CUT2 93.9 92.9 99.0 99.0 98.4 97.7 97.6 98.8 97.6 97.2 98.9 98.5 98.9 98.7 98.7 98.3 98.7 96.2 98.5 95.3
Ark99 94.8 92.8 97.0 97.0 96.6 95.6 97.4 96.6 97.4 96.3 97.5 97.2 97.7 97.3 97.3 97.0 97.3 96.0 97.2 94.9
ADPI 94.7 93.2 99.9 99.9 99.2 98.8 98.1 99.6 98.1 98.9 96.9 99.6 99.2 99.8 99.8 99.4 99.8 96.4 99.6 95.5
DE072 94.6 93.3 100 100 99.3 98.6 98.2 99.7 98.2 99.0 97.0 99.9 98.9 99.4 99.7 99.1 99.4 96.0 99.2 95.1
CU805 93.5 92.5 97.8 97.8 97.1 96.7 96.3 97.7 96.3 96.9 95.6 97.7 97.8 99.1 99.1 98.7 99.1 96.6 98.9 96.0
CU570 94.0 92.8 99.2 99.2 98.5 98.6 97.4 98.9 97.4 98.2 96.2 99.3 99.2 97.3 99.6 99.2 99.6 96.2 99.5 95.5
GA98 94.6 93.1 99.7 99.7 99.0 98.6 98.2 99.5 98.2 98.8 97.0 99.9 99.7 97.6 99.2 99.2 99.6 96.2 99.3 95.3
Cal99 94.8 93.6 99.7 99.7 99.0 98.4 98.5 99.1 98.5 98.8 97.3 99.6 99.7 97.6 98.9 99.5 99.2 95.8 99.1 95.1
CU994 94.4 93.2 99.6 99.6 98.9 98.2 98.1 99.3 98.1 98.6 96.9 99.5 99.6 97.4 98.8 99.3 99.6 96.2 99.4 95.3
K1699 90.8 89.7 92.1 92.1 91.9 92.1 91.5 92.0 91.5 91.3 91.2 92.3 92.1 91.6 92.3 92.1 92.3 92.0 96.0 95.7
Gray 94.6 92.8 99.5 99.5 98.8 98.4 98.0 99.2 98.0 98.5 96.7 99.6 99.5 97.3 98.9 99.7 99.2 99.0 91.9 95.1
BJ 84.8 84.6 85.8 85.8 85.5 84.6 85.6 85.8 85.6 85.4 85.0 85.6 85.8 85.2 85.2 95.5 85.9 85.6 86.0 85.2
N-terminal coding region
Sequences with >95% identity are indicated in bold letters.
a Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.
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the nt sequences of the entire 5V terminal region (Fig. 2a). No
detectable sequence similarity was found when IBV 5V
terminal sequences were compared to those of coronaviruses
from other groups (data not shown).                    
Fig. 1. Alignment of the first 80 nucleotides from cDNA sequences derived from
differences between sequences. The leader sequence is denoted by a solid blackThe PLpro domains (nt 4243–5553: aa 1239–1675)
Sequence distance data derived from multiple align-
ments of the two overlapping PLpro domains of IBV strains
revealed 77.6–100% identity in PL1pro and 79–100% in                      
 
the 5V end of 22 heterologous IBV strains. The gray shading represents
line above the sequence and the leader junction sequence is boxed.
  
  
 
 
 
 
Fig. 2. Phylogenetic trees showing the relatedness among the 5V-terminal sequences (a), PLpro (b), Mpro (c), RdRp (d) domains and S1 glycoprotein genes (e) of
22 heterologous IBV strains. A cluster of contemporary field isolates and vaccine strains is indicated with a dashed box (: : : : : :) in a and in b. The neighbor-
joining tree was constructed from the pairwise nucleotide differences for 5V-termini and deduced amino acid differences in all other respective genes. The length
of each pair of branches represents the distance between sequence pairs. The scale at the bottom indicates the number of substitution events.
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(Table 2). The BJ strain differed the most from other strains
by 18.1–22.4% in PL1pro and 16.5–21% in PL2pro. The
catalytic Cys1274 and His1437 residues in the PLpro domains
are conserved in all IBV strains (Fig. 3). In the overlapping
area of the PLpro domains, a region of 24 residues with
more heterogeneity has been identified, where only two
residues (Phe1470 and Lys1485) are conserved among all
IBV strains (Fig. 3). In this heterogeneous region, the
vaccine and challenge M41 and BJ strains each differed
by 12 aa (50%), Conn, CU510, Florida, CU805, and Gray
each differed by 11 aa (45%), CU705, Ark99, and Cal99
strains each differed by 10 aa (40%), and all other strains
are identical to each other and differed by 9 aa (37.5%)
when compared to the Beaudette strain sequence. In the
complete PLpro domain, the NV M41 challenge strain has 1
nt and 1 aa difference from the M41 vaccine strain. The
relationships between the different sequences are shown in
the phylogenetic tree derived from analysis of the aa
sequences of the entire PLpro region (aa 1239–1675)
(Fig. 2b). No detectable sequence similarity was found
when IBV PLpro sequences were compared to the PLpro
sequences of coronaviruses from other groups (data not
shown).The M pro (aa ORF1a 2804–2943) and the RdRp (aa ORF1b
548–780) domains
The alignments of the deduced aa sequences of IBV
Mpro and RdRp domains are summarized in Table 3. The
overall sequences are highly conserved in which there are
82.7% (116 aa) absolutely conserved residues in Mpro and
92.7% (216 aa) absolutely conserved residues in RdRp
(data not shown). The remaining 24 aa differences found
in Mpro and 17 aa differences in RdRp are distributed
throughout the domains (Table 3). The Mpro and RdRp
domains of ArkDPI, GA98, and Gray strains are identical to
each other and those of the challenge NV M41 and vaccine
M41 strains are also identical to each other. These relation-
ships are graphically shown in the phylogenetic tree created
from the aa sequences of the Mpro and RdRp domains (Figs.
2c and d).
By aligning with the corresponding regions of prototype
members of other coronavirus groups, all Mpro had 28% (40
aa) absolutely conserved residues including catalytic Cys-
His dyad and three substrate-binding sites (Tyr-Met-His),
and the RdRp had 47.6% (111 aa) absolutely conserved
residues (data not shown). The four RdRp motifs (DXXXD,
SGXXXTXXXN, SDD, and K) appear to be fully conserved
Table 2
Amino acid identities in PL1pro (aa 1239–1497) and PL2pro (aa 1385–1675) of the replicase gene of 21 IBV strains
Virus PLPD-1
Beau M41a Ma5 H52 K0
751
CU
705
Conn CU
510
Flori CUT2 Ark99 Ark
DPI
DE
072
CU
805
CU
570
GA
98
Cal99 CU
994
K1
699
Gra BJ
Beau 88.8 83.4 83.4 82.6 81.5 87.3 81.9 87.3 85.3 87.3 83.0 83.0 82.2 83.0 83.0 81.9 83.0 85.7 87.3 80.7
M41a 89.0 84.6 84.6 83.4 82.6 85.7 82.2 85.7 86.9 90.7 84.2 84.2 82.6 84.2 84.2 83.0 84.2 84.9 85.7 81.9
Ma5 84.2 86.9 100 96.5 98.1 84.2 96.5 84.2 91.1 84.9 99.6 99.2 95.8 99.6 99.6 97.3 99.6 86.9 84.2 80.3
H52 83.8 86.6 99.7 96.5 98.1 84.2 96.5 84.2 91.1 84.9 99.6 99.2 95.8 99.6 99.6 97.3 99.6 86.9 84.2 80.3
K0751 83.8 86.6 99.3 99.0 95.4 86.9 93.8 86.9 93.8 86.1 96.1 95.8 97.7 96.7 96.1 96.1 96.1 89.6 86.9 79.9
CU705 83.2 85.9 99.0 99.3 98.3 82.2 96.1 82.2 89.2 83.8 97.9 97.3 94.6 97.7 97.7 95.4 97.7 84.9 82.2 79.9
Conn 87.3 87.3 84.9 84.5 84.5 83.8 81.7 100 91.1 88.0 83.8 83.8 86.1 84.6 83.3 84.9 83.8 95.3 100 77.6
CU510 82.8 84.9 96.6 96.9 95.9 96.9 82.8 81.9 87.6 83.8 96.1 98.5 93.1 96.1 96.1 93.8 96.1 83.8 81.9 78.4
Florida 87.3 87.3 84.9 84.5 84.5 83.8 99.9 82.8 91.1 88.0 83.8 83.8 86.1 94.6 83.3 84.9 83.8 95.3 100 77.6
CUT2 84.9 87.3 97.6 97.9 96.9 97.3 85.2 94.8 85.2 88.0 90.7 90.7 93.1 91.5 90.7 90.7 90.7 93.1 91.1 80.7
Ark99 87.6 89.7 84.5 84.2 84.2 83.5 92.8 82.8 92.8 84.9 84.6 84.6 84.6 85.3 84.6 84.9 84.9 87.6 88.0 81.5
ADPI 84.2 86.9 100 99.7 99.3 99.0 84.9 96.6 84.9 97.6 84.5 98.8 95.4 99.2 99.2 96.9 99.2 86.5 83.8 80.3
DE072 83.5 86.3 99.0 99.3 98.3 98.6 84.2 96.2 84.2 97.6 83.8 99.0 95.0 98.8 99.3 96.5 98.8 86.5 83.8 79.9
CU805 82.5 84.9 97.3 97.3 96.6 97.6 82.8 95.5 82.8 95.5 82.5 97.3 96.9 96.1 95.4 95.4 95.4 88.8 86.1 78.8
CU570 83.8 86.6 99.7 99.3 99.0 98.6 84.5 96.2 84.5 97.3 84.2 99.7 98.6 96.9 99.2 96.9 99.2 87.3 84.6 79.9
GA98 83.8 86.6 99.7 99.3 99.0 98.6 84.5 96.2 84.5 97.3 84.2 99.7 98.6 96.9 99.3 97.7 99.2 86.5 83.8 79.9
Cal99 83.8 86.6 99.3 99.0 98.6 98.3 85.2 95.9 85.2 96.9 84.9 99.3 98.3 96.6 99.0 99.0 96.9 86.9 84.9 78.0
CU994 83.2 85.9 99.0 98.6 98.3 97.9 84.5 95.5 84.5 96.6 83.5 99.0 97.9 96.2 98.0 98.6 98.3 86.9 83.8 80.3
K1699 81.4 82.8 84.2 83.8 83.6 83.2 82.8 82.1 82.8 84.9 83.5 84.2 83.5 82.5 83.8 83.8 83.8 84.2 90.3 80.7
Gray 86.9 86.9 84.5 84.2 84.2 83.5 99.7 82.5 99.7 84.9 92.4 84.5 83.8 82.8 84.2 84.2 84.9 84.2 82.5 77.6
BJ 81.1 83.5 81.4 81.1 80.8 80.4 80.8 79.0 80.8 82.1 82.5 81.4 80.8 79.7 81.1 81.1 81.1 81.4 82.1 80.4
PLPD-2
Sequences with >95% identity are indicated in bold letters.
a Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.
S.P. Mondal, C.J. Cardona / Virology 324 (2004) 238–248242in all coronaviruses. The IBV Mpro domains have 38.7–
40.1% similarity with 229E, 45.1–45.8% with TGEV, 38.5–
41.5% with MHV, 39.2–41.5% with BoCV, and 43.4–
44.8% with the SARS coronavirus in pairwise comparisons.
Whereas the IBV RdRp has 60.9–62.7% similarity withFig. 3. Amino acid sequence alignment of the papain-like proteinase domains of 22
asterisks (*) and the more variable region marked by thick bar (—) below the alignm
ended at the labeled residue. The internal sequences not presented in this alignm229E, 60.4–61.8% with TGEV, 66.5–68.7% with MHV,
66.1–68.2% with BoCV, and 66.1–68.2% with SARS
coronavirus. The phylogenetic trees created from both Mpro
and RdRp of various coronaviruses cluster into the three
major antigenic groups (data not shown).IBV strains indicating the catalytic Cys1274 and His1437 residues marked as
ent. Residue numbers are given above the sequence; four-digit numbers are
ent are indicated by dashes (– – – ).
Table 3
Amino acid exchanges in the main protease (aa ORF1a 2804–2943) and the RNA-dependent RNA polymerase (aa ORF1b 548–780) domains among 21 IBV strains
Strains Exchange of aa in the Mpro at positiona Exchange of aa in the RdRp at positiona
2814 2815 2829 2831 2835 2840 2845 2847 2848 2849 2851 2855 2860 2874 2881 2894 2898 2900 2906 2925 2928 2929 2935 2937 569 572 592 596 606 608 611 674 678 681 698 708 744 752 754 756 765
Beau T I Q N N H T Q H G T V K E I A T V T V N I N F E I A V S S I I N S P L V F A S E
M41b S . . G . . V . N . . . . . V S . I . . . . . . . . . . T . V D . . . . . . . .
Ma5 . . . . . Y V . N N . . . . V S . . I P . . . Y . . . . T P . . D D S . I Y . P .
H52 . . . . . . V . N N . . . . V S . . . P . . . Y . . . . T P . . D D S . I Y S . .
K0751 . . . S . Y V . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S . .
CU705 . . . . . . V . N N . . . . V S . . I P . . . Y . . . . T . . . D . . . . . S . .
Conn . . . S . . A . N . . . R D V S . . . . . . . . . . . T . . . D . . . . . S . .
CU510 . . . . . . V . N N . . . . V S . . . P . V . Y . . . . T . . . D . . . . . S . .
Florida . . . S . . A . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S . .
CUT2 . . H S . . V . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S . .
Ark99 . . . S . . A . N . I . R D V S . . . . . . . . . . . . T . . . D . . . . . S . .
ArkDPI . . . S . . A . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S A .
DE072 . . . . Y . V . N N . . . . V S . . . P . . . Y . . . . T P . . D D S . I Y . . G
CU805 . . . . . . V . N N . . . . V S . . . P . . . Y . . . I T . . V D . . . . . S . .
CU570 . . . S . . A . N . . . R D V S S . . . . . S . . . . . T . . . D . . . . . S . .
GA98 . . . S . . A . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S A .
Cal99 . . . . . . V . N N . . R D V S . . . . . . . . A . V . T . . . D . . . . . S . .
CU994 . . . S . . A . N . . R D V S . . . . T . . . . . V . T . . . D . . . . . S . .
K1699 . V . S . . A . N . . I R D V S . . . . . . . . . . . I T . . . D . . . . . S . .
Gray . . . S . . A . N . . . R D V S . . . . . . . . . . . . T . . . D . . . . . S A .
BJ S . . D . . V G N . . . R . M S . I . . . . . . . M . . T . . . D . . M I Y . . .
a
Amino acid residues identical to that of Beaudette virus are indicated as dots (.).
b
Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.
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The findings of the present study can be summarized as:
(i) the Mpro and RdRp regions are highly conserved among
all coronaviruses unlike the 5V-terminal sequence and PLpro
domains, (ii) the clustering of heterologous IBV strains
based on the replicase gene sequences does not correlate
with the antigen-based S1 phylogeny, (iii) several widely
used IBV vaccines and field strains isolated over the past
decade have closely related replicase genes suggestive of a
possible common ancestry or a converging evolution, and
(iv) the replicase gene is unlikely to be the sole determinant
of IBV pathogenicity.
Coronaviruses fall into three antigenic groups (Dea et al.,
1990), which are defined by cross-reactivity among the
structural proteins. Unlike the structural proteins, the coro-
navirus replicase gene is not subjected to immune selective
pressure. Therefore, one would expect that the replicase
gene would be highly conserved among coronavirus groups.
In fact, this is the case when the Mpro and RdRp sequences
are compared (Table 3) and as others have reported for other
coronavirus groups (Chouljenko et al., 2001; Gonzalez et
al., 2003; Hegyi and Ziebuhr, 2002; Stephensen et al.,
1999). We found a high percentage of sequence similarities
in coronavirus Mpro (with 28% absolutely conserved resi-
dues), including the substrate recognition site, and an even
higher similarity in the RdRp (with 48% absolutely con-
served residues), including the polymerase motifs. However,
two-way sequence comparisons of the coronavirus 5V-ter-
mini and the PLpro domains of ORF1a had very low
sequence identity between coronaviruses of different groups
as has been reported by others (Herold et al., 1999). Despite
the fact that these regions have varying degrees of genetic
diversity, the relationships between the coronaviruses of
different groups are the same, no matter what region of
the genome is compared. When recombination occurs
(Cavanagh and Davis, 1988), it would seem to occur within
the major coronaviruses antigenic groups, but not between
them. This is expected because in order for recombination to
occur, two viruses must be present in the same cell, which is
unlikely between coronaviruses adapted to different host
species. The highly conserved Mpro-mediated processing
pathways as well as the substrate binding sites of this
enzyme in all coronaviruses (Anand et al., 2003; Hegyi
and Ziebuhr, 2002) make this proteinase an attractive target
for the development of drugs directed against coronaviruses.
The active domains of RdRp also maintain a high degree of
homology among all coronaviruses, as has been found in
other RNA viruses (Koonin and Dolja, 1993; Otsuka et al.,
1999), making this proteinase another potential target for
drugs controlling coronaviruses.
With IBV, the phylogenies of the four regions of the
replicase gene did not correlate with those of the S1 gene,
which correspond to the type-specific antigenic groups
(Fig. 2). For example, unlike the S1 genes, the replicase
genes of the Ma5 and H52 Mass serotype viruses consis-tently clustered with those of non-Mass strains (Figs. 2a–
d). The common clustering of replicase genes of these
heterologous IBV strains could be due to an introduction of
a replicase gene from a common source through introduc-
tion. Others have speculated that IBV strains substitute
large genomic fragments in multiple genes (Lee and Jack-
wood, 2000) because the viability of the progeny viruses
depends on the specific interactions of more than one gene
working in concert to maintain structural and replicative
integrity. Alternatively, it is probably more likely that the
smaller S1 genes are exchanged between viruses through
recombination and the stable replicase backbone is main-
tained. It is entirely possible that recombination events have
occurred to introduce new replicase or new S1 genes into
these viruses.
Leader acquisition in mRNA synthesis appears to be
TRS dependent, and the leader-to-body joining is guided by
a base-pairing interaction involving leader and body TRSs
(Hiscox et al., 1995; Pasternak et al., 2001). The phenom-
enon of leader switching involves a recombination event
over a region comprising the leader sequence and the
adjacent 5V UTR (Chang et al., 1996). Previous reports have
suggested that the leader sequences of IBV strains may
contain higher (17.2%) substitution rates when compared to
the complete 5V UTR (4.3%; Stirrups et al., 2000). In our
study, the 5V UTR of all 22 IBV strains are highly conserved
(94–100% identity), indicating the exchange of leader or
adjacent 5V UTR fragments has occurred in mixed infec-
tions. This observation is supported by experimental evi-
dence of the exchange of leader sequences among
heterologous IBV strains (Stirrups et al., 2000) and in mixed
MHV infections (Makino et al., 1986). The sequence
comparison scores are more variable in the N-terminal
coding region (Table 1), and the most in PLpro domains
(Table 2) including a more variable region in the latter (Fig.
3) than the IBV Mpro and RdRp domains (Table 3). The
reason for sequence variation in the N-terminal half of
ORF1a among IBV strains is not clear.
The genetic variations in the 5V terminal region and PLpro
gene suggest that there is some selective pressure on these
regions. We speculate that there are some replicase geno-
types that may confer a selective advantage to the virus. We
examined both the 5V terminal region and the PLpro gene by
year and location of isolation, but excluded the Mpro and
RdRp genes because they are so highly conserved that no
clear differences between isolates can be discerned. In the 5V
terminal region and the PLpro gene, the IBV strains isolated
from commercial chickens over the past decade cluster with
three specific vaccine virus strains, ArkDPI, H52, and Ma5,
no matter where in the United States they were isolated.
There are three exceptions to this clustering, the 5V terminal
region of the Gray virus isolated in 1960 (Winterfield and
Hitchner, 1962) clusters with modern field strains (Fig. 2a),
although its PLpro gene is more like the Conn and Florida
reference viruses isolated in 1956 and 1971, respectively
(Jungherr et al., 1956; Winterfield et al., 1971) (Fig. 2b). In
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China (BJ) and one from California (K1699) isolated in
2003 and 2001, respectively, that are outliers and do not
appear to have 5V termini or PLpro genes that are related to
other viruses (Figs. 2a and b). This common clustering of
three widely used vaccines and IBV field isolates from the
past decade suggests to us that there may be a common
evolutionary progression in the 5V terminal region and in the
PLpro gene. Although the 5V terminal region genotype found
in modern isolates was present in 1960, when the Gray virus
was isolated, it appears to be more prevalent today. The
question arises as to why this type of progression to a
specific genotype would have occurred and how it could
have happened. As to the question of why, we speculate that
the more modern genotype must offer some fitness advan-
tage to the virus. As to how it could have occurred, we
consider the widespread use of multiple types of modified
live vaccines in both the broiler and egg layer commercial
poultry industries as the possible mechanism by which this
modern replicase gene genotype was introduced. The Ark,
Conn, and Mass (Ma5, H52) strains have been used simul-
taneously as live vaccines among commercial poultry (Cav-
anagh and Naqi, 2003). Although we cannot prove or
disprove that recombination has occurred, we can point to
the evolutionary trends in the S1 gene as compared to the
evolutionary trends in the replicase gene. The trends in S1
evolution have been toward ever increasing diversity (Jia et
al., 2002), while it appears that the replicase gene is
evolving to less variety between isolates. These juxtaposed
evolutionary trends suggest that (1) these two regions are
under very different selective pressures and thus undergo
much different rates and modes of change, and (2) the
exchange of genetic material may have occurred between
vaccine strains and field isolates.
The genetic basis of IBV pathogenicity is not known.
The role of the replicase gene in the virulence of IBV has
not been established, and it is likely that some changes in
the Mpro or viral polymerase would influence viral replica-
tion rate, and thus the pathogenic potential of a virus. In
some RNA viruses, replicase genes are known to contain the
determinants of species tropism and virulence factors
(Brandt et al., 2001; Hatta et al., 2001; Yao et al., 2001).
In our study, there were no differences in any essential
residues in Mpro and RdRp domains. In addition, we found
that there was no clear relationship between viral pathotype
and replicase genotype. As an example, the H52 vaccine
strain is very closely related to the virulent DE072 isolate in
all regions of the replicase (99.8% identity in the 5V
terminus, 99.5% in PLpro, 99.3% in Mpro, 99.6% in RdRp)
despite their differences in pathotype. In addition, a direct
comparison of the replicase genes of the M41 challenge and
vaccine strains where there were very few aa differences
between the two strains with clearly different pathotypes.
None of the aa changes between the two M41 strains were
consistently observed in either all virulent or all avirulent
strains. These findings would support our contention thatthe genotype of the replicase is not the sole determinant of
pathogenicity among strains of IBV.Materials and methods
Experimental design
Twenty IBV strains from nine different serotypes, Mass
(M41, NV M41, Ma5, H52, K0751, CU705), Conn (Conn,
CU510), Florida, CU-T2, Arkansas (Ark-99, ArkDPI), Del-
aware 072 (DE072, CU805, CU570), Georgia 98 (GA98),
California 99 (Cal99, CU994, K1699), and Gray, were used
in this study (Table 4). These virus strains were selected
because they are very common vaccine and field strains that
are frequently isolated from commercial chickens and are
associated with clinical disease. All the reference IBV
strains were obtained from Dr. Syed Naqi’s laboratory
(Cornell University, Ithaca), where they had been propagat-
ed in specific pathogen-free (SPF) embryonated chicken
eggs to maintain the stock. In our laboratory, all of the
viruses were also propagated in 9-day-old embryonated SPF
eggs (Charles River SPAFAS, Wilmington, MA). Four
regions of the replicase gene from 20 heterologous IBV
strains, which correspond to the 5V-termini, and the PLpro,
the Mpro, and the RdRp domains (Fig. 4), were sequenced
and compared with those of previously published IBV
(Beaudette, BJ) and other coronavirus sequences.
Viral RNA extraction, RT-PCR amplification and
sequencing
Genomic RNAwas extracted from virus-inoculated allan-
toic fluid with TRIzol reagent (Invitrogen Co., Carlsbad, CA)
following the manufacturer’s instructions. The first strand
cDNA synthesis and subsequent PCR were performed using
GeneAmp RNA PCR kit (Perkin-Elmer Cetus, Norwalk, CT)
following the manufacturer’s instructions. The selected
regions of the replicase genes were amplified with primers
synthesized from conserved regions designed by aligning
IBV Beaudette sequence and sequences from other corona-
viruses. The PCR profiles involved an initial denaturation for
4 min at 94 jC followed by 35 cycles of annealing at 55 jC
for 30 s, extension at 72 jC for 1min, andmelting at 94 jC for
1 min. The amplified products were directly sequenced at a
commercial sequencing facility (Davis Sequencing, Davis,
CA). The genome sense Pol32 (5V-CACTAGCCTTGCGC-
TAGA-3V) and anti-sense Pol1501 (5V-GACCAACC-
TTCTGGTTCAAC-3V) primers were used to amplify the
5V-termini that correspond to nt 32–1501 of the Beaudette
sequence (Boursnell et al., 1987). The 5V ends of all IBV
strains were amplified with FirstChoice RLM-RACE cDNA
amplification kit (Ambion Inc., Austin, TX) using genomic
antisense Pol1263 (5V-GCTTGCAAGACAAGTTCCTGC-
3V) primer according to the manufacturer’s protocol. The
Pol1263 paired with another inner site primer Pol133 (5V-
Table 4
IBV strains examined in this study
Straina Serotype Geographic origin Original description or source
(reference)
GenBank
accession no.b
Beaudette Massachusetts New Jersey, USA Laboratory strainc M95169
M41 Massachusetts Massachusetts, USA Jungherr et al. (1956) AY561711
NV M41 Massachusetts USA Challenge strain (NVSL, USDA) AY561712
Ma5 Massachusetts Europe Vaccine straind (Intervet Inc.) AY561713
H52 Massachusetts Europe Vaccine straind (Intervet Inc.) AF352315
K0751 Massachusetts California, USA Field isolatee (UCDavis, 2001) AY561714
CU705 Massachusetts New York, USA Field isolatee (Cornell Univ., 2002) AY561715
Conn Connecticut Connecticut, USA Jungherr et al. (1956) L18990
CU510 Connecticut New York, USA Field isolatee (Cornell Univ., 2002) AY561716
Florida Florida Florida, USA Winterfield et al. (1971) AF027512
CU-T2 CU-T2 New York, USA Jia et al. (1995) U04739
Ark99 Arkansas Arkansas, USA Johnson et al. (1973) L10384
ArkDPI Arkansas Delmarva, USA Gelb et al. (1981) AF006624
DE072 DE072 Delmarva, USA Gelb et al. (1997) U77298
CU805 DE072 New York, USA Mondal et al. (2001) AF317215
CU570 DE072 New York, USA Field isolatee (Cornell Univ., 2003) AY561717
GA98 GA 98 Georgia, USA Lee and Jackwood (2001) AF274437
Cal99 Cal99 California, USA Martin et al. (2001) AY514485
CU994 Cal99 New Mexico, USA Field isolatee (Cornell Univ., 2000) AF317499
K1699 Cal99 California, USA Field isolatee (UCDavis, 2001) AY561718
Gray Gray Delmarva, USA Winterfield and Hitchner (1962) L14069
BJ Unknown China GenBank (China, 2003) AY319651
a Except for the Gray strain that is nephrotropic and the BJ strain whose tissue tropism is unknown, all other strains are pneumotropic.
b Based on S1 gene sequence.
c Extensively propagated in vitro since the first isolation (Beaudette and Hudson, 1937) and known to be attenuated.
d Introduced to the US market at about 1990 (Ma5) and 1980 (H52).
e IBV recovered from infected chicken flocks and associated with clinical disease and their serotype determined by S1 sequence.
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served areas (by aligning 11 IBV sequences including the
Beaudette virus) could amplify nt 133–1263 (according to
Beaudette sequence) of all IBV strains tested in our labora-
tory (data not shown). Three more consensus primer pairs
were used to amplify other regions as follows: primers for the
overlapping PLpro amplification are PL55 (5V-AGGATAAA-
GAAATYCTCTTC-3V) and PL58 (5V-GGACCACAYAAA-
GAACCCTC-3V); primers for Mpro amplification are Mp51
(5V-CGCCACGTTACTCTATTGGT-3V) and Mp33 (5V-
GCCGCATAGAGCCATGCTAC-3V); and primers for RdRp
amplification are Rp52 (5V-CTACTATGACTAATAGG-
CAG-3V) and Rp31 (5V-CTGAGAAAGCTCTTGATAGAG-
3V).
Sequence analysis
Assembly of contiguous sequences, translation of nt
sequence into protein sequence, and initial multiple sequenceFig. 4. Diagram of the coronavirus replicase gene (encoding ORF 1a and 1b) illust
protease (Mpro), RNA-dependent RNA polymerase (RdRp), metal-binding (MB),
Mpro indicate the cleavage sites. The four regions amplified in this study are indialignments were performed with Vector NTI Suite 9 software
(InforMax, North Bethesda, MD). Selected sequences from
GenBank were included in the alignment. After the align-
ment, the AlignX program constructs a phylogenetic tree
employing the neighbor-joining method. Comparisons with
published sequences were made by performing BlastN search
(GenBank). Pairwise blast searches were also performed
when there were no significant hits with BlastN search.
GenBank accession numbers
The accession numbers for IBV replicase gene sequences
are as follows: (a) the 5V-termini: M41, AY392047; NVM41,
AY561719; Ma5, AY561720; H52, AY392048; K0751,
AY561721; CU705, AY561722; Conn, AY392049; CU510,
AY561723; Florida, AY392050; CU-T2, AY561724; Ark99,
AY392051; ArkDPI, AY392052; DE072, AY392054;
CU805, AY561725; CU570, AY561726; GA98,
AY392053; Cal99, AY392055; CU994, AY561727; K1699,rating the 5V untranslated region (UTR), papain-like proteinase (PLpro), main
and RNA helicase (RH) domains. The arrows originating from PLpro and
cated as shading areas with arrow at each end (bottom).
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AY392057; NV M41, AY561729; Ma5, AY561730; H52,
AY392058; K0751, AY561731; CU705, AY561732; Conn,
AY392059; CU510, AY561733; Florida, AY392060; CU-
T2, AY561734; Ark99, AY392061; ArkDPI, AY392062;
DE072, AY392064; CU805, AY561735; CU570,
AY561736; GA98, AY392063; Cal99, AY392065; CU994,
AY561737; K1699, AY561738; Gray, AY392066; (c) the
Mpro: M41, AY392067; NV M41, AY561739; Ma5,
AY561740; H52, AY392068; K0751, AY561741; CU705,
AY561742; Conn, AY392069; CU510, AY561743; Florida,
AY392070; CU-T2, AY561744; Ark99, AY392071;
ArkDPI, AY392072; DE072, AY392074; CU805,
AY561745; CU570, AY561746; GA98, AY392073; Cal99,
AY392075; CU994, AY561747; K1699, AY561748; Gray,
AY392076; (d) the RdRp: M41, AY392077; NV M41,
AY561749; Ma5, AY561750; H52, AY392078; K0751,
AY561751; CU705, AY561752; Conn, AY392079; CU510,
AY561733; Florida, AY392080; CU-T2, AY561754; Ark99,
AY392081; ArkDPI, AY392082; DE072, AY392084;
CU805, AY561755; CU570, AY561756; GA98,
AY392083; Cal99, AY392085; CU994, AY561757; K1699,
AY561758; Gray, AY392086.
The complete genome sequences of Beaudette (M95169)
and BJ (AY319651) strains of IBV, HcoV 229E
(NC_002645), TGEV (NC_002306), MHV (NC_001846),
BoCV (NC_003045), and SARS (NC_004718) were
obtained from GenBank. The S1 sequences of IBV strains
were also obtained from GenBank (Table 4).Acknowledgments
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